Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Immunochemical Methods in Health Risk Assessment: Cross Reactivity of Antibodies against Mycotoxin Deoxynivalenol with Deoxynivalenol-3-glucoside

Jiří Ruprich, Vladimír Ostrý

. 2008 ; 16 (1) : 34-37.

Jazyk angličtina Země Česko

Perzistentní odkaz   https://www.medvik.cz/link/bmc07509274

Co-occurrence of deoxynivalenol (DON) with other DON derivatives/metabolites and other Fusarium toxins, including zearalenone, nivalenol and as well as other mycotoxins (e.g. fumonisins) is frequently observed in food and feed. DON-3ß-glucopyranoside (DON-3-glucoside) was described as detoxification product of DON in wheat. This mycotoxin conjugate was observed in maize, barley, malt, beer and wort. Digestion of this conjugate in intestine is still unclear but due to possibility to release DON after hydrolysis is considered as potential masked mycotoxin. DON is analytically quantified by various methods and also with immunochemical methods. There is no available information about specificity of anti-DON antibodies used in commercial ELISA kits with DON-3-glucoside. Preliminary testing of anti-DON monoclonal antibodies used in ELISA kits RIDASCREEN®DON (R-Biopharm AG, Germany) approved a hypothesis that these antibodies have high relative cross reactivity with DON-3-glucoside. In two repeated tests cross reaction 82 and 98% were observed. Analytical results produced by these ELISA kits can be interpreted as an approximate sum of both mycotoxins. Described cross reactivity can lead to overestimating of DON concentration. Over these cross reactions immunochemical methods are mentioned still valuable for quantitative screening and even for an initial exposure assessment in situations when there are practical or economical reasons not to use another analytical method with a reasonable low limit of quantification (< 50 ppb).

Citace poskytuje Crossref.org

Bibliografie atd.

Lit.: 16

000      
03517naa 2200421 a 4500
001      
bmc07509274
003      
CZ-PrNML
005      
20111210123444.0
008      
080923s2008 xr e eng||
009      
AR
024    7_
$a 10.21101/cejph.a3455 $2 doi
035    __
$a (PubMed)18459478
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Ruprich, Jiří, $d 1954- $7 ola2002110019
245    10
$a Immunochemical Methods in Health Risk Assessment: Cross Reactivity of Antibodies against Mycotoxin Deoxynivalenol with Deoxynivalenol-3-glucoside / $c Jiří Ruprich, Vladimír Ostrý
314    __
$a National Institute of Public Health in Prague, Centre for the Hygiene of Food Chains in Brno
504    __
$a Lit.: 16
520    9_
$a Co-occurrence of deoxynivalenol (DON) with other DON derivatives/metabolites and other Fusarium toxins, including zearalenone, nivalenol and as well as other mycotoxins (e.g. fumonisins) is frequently observed in food and feed. DON-3ß-glucopyranoside (DON-3-glucoside) was described as detoxification product of DON in wheat. This mycotoxin conjugate was observed in maize, barley, malt, beer and wort. Digestion of this conjugate in intestine is still unclear but due to possibility to release DON after hydrolysis is considered as potential masked mycotoxin. DON is analytically quantified by various methods and also with immunochemical methods. There is no available information about specificity of anti-DON antibodies used in commercial ELISA kits with DON-3-glucoside. Preliminary testing of anti-DON monoclonal antibodies used in ELISA kits RIDASCREEN®DON (R-Biopharm AG, Germany) approved a hypothesis that these antibodies have high relative cross reactivity with DON-3-glucoside. In two repeated tests cross reaction 82 and 98% were observed. Analytical results produced by these ELISA kits can be interpreted as an approximate sum of both mycotoxins. Described cross reactivity can lead to overestimating of DON concentration. Over these cross reactions immunochemical methods are mentioned still valuable for quantitative screening and even for an initial exposure assessment in situations when there are practical or economical reasons not to use another analytical method with a reasonable low limit of quantification (< 50 ppb).
650    _2
$a mykotoxiny $x izolace a purifikace $x škodlivé účinky $x toxicita $7 D009183
650    _2
$a hodnocení rizik $x metody $x normy $x využití $7 D018570
650    _2
$a imunochemie $x metody $x normy $7 D007120
650    _2
$a imunoanalýza $x metody $x využití $7 D007118
650    _2
$a monoklonální protilátky $x diagnostické užití $7 D000911
650    _2
$a trichotheceny $x diagnostické užití $7 D014255
650    _2
$a Fusarium $x izolace a purifikace $7 D005670
650    _2
$a ELISA $x metody $x využití $7 D004797
650    _2
$a interpretace statistických dat $7 D003627
650    _2
$a zkřížené reakce $x imunologie $7 D003429
700    1_
$a Ostrý, Vladimír, $d 1957- $7 mzk2003169479
773    0_
$w MED00001083 $t Central European journal of public health $g Roč. 16/52, č. 1 (2008), s. 34-37 $x 1210-7778
856    41
$u http://www.szu.cz/svi/cejph/archiv/2008-1-08.pdf $y plný text volně přístupný
910    __
$a ABA008 $b B 1829 $c 562 $y 1
990    __
$a 20080923083420 $b ABA008
991    __
$a 20080923122431 $b ABA008
999    __
$a ok $b bmc $g 624865 $s 477300
BAS    __
$a 3
BMC    __
$a 2008 $b 16 $c 1 $d 34-37 $i 1210-7778 $m Central European Journal of Public Health $x MED00001083
LZP    __
$a 2008-31/vtal

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...